In the context of AD, alternative splicing of APOER2 has been differentially observed, with lower inclusion rates of exon 18 (ex18 in humans, ex19 in mice) compared to individuals without cognitive impairment [13]. This evidence concerns the gene LRP8 and Alzheimer disease.